Methylprednisolone Sodium Succinate (Page 6 of 6)

Methylprednisolone Sodium Succinate for Injection, USP 125 mg* per vial-Vial Label

container2
(click image for full-size original)

Methylprednisolone Sodium Succinate for Injection, USP 500

container3
(click image for full-size original)

Methylprednisolone Sodium Succinate for Injection, USP 1g* per vial-Vial Label

container4
(click image for full-size original)

Methylprednisolone Sodium Succinate for Injection, USP 40 mg* per vial — carton label

carton1
(click image for full-size original)

Methylprednisolone Sodium Succinate for Injection, USP 125 mg* per vial — carton label

carton2
(click image for full-size original)

Methylprednisolone Sodium Succinate for Injection, USP 500 mg* per vial — carton label

carton3
(click image for full-size original)

Methylprednisolone Sodium Succinate for Injection, USP 500 mg* per vial — carton label

carton4
(click image for full-size original)

METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:43598-127
Route of Administration INTRAVENOUS, INTRAMUSCULAR DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
METHYLPREDNISOLONE SODIUM SUCCINATE (METHYLPREDNISOLONE) METHYLPREDNISOLONE 40 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 1.84 mg in 1 mL
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS 17.46 mg in 1 mL
LACTOSE MONOHYDRATE 25 mg in 1 mL
Product Characteristics
Color WHITE (white to off-white) Score
Shape Size
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:43598-127-25 25 VIAL, SINGLE-DOSE in 1 CARTON contains a VIAL, SINGLE-DOSE (43598-127-45)
1 NDC:43598-127-45 1 mL in 1 VIAL, SINGLE-DOSE This package is contained within the CARTON (43598-127-25)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA212396 03/24/2022
METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:43598-129
Route of Administration INTRAVENOUS, INTRAMUSCULAR DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
METHYLPREDNISOLONE SODIUM SUCCINATE (METHYLPREDNISOLONE) METHYLPREDNISOLONE 125 mg in 2 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 1.84 mg in 2 mL
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS 17.4 mg in 2 mL
Product Characteristics
Color WHITE (white to offi-white) Score
Shape Size
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:43598-129-25 25 VIAL, SINGLE-DOSE in 1 CARTON contains a VIAL, SINGLE-DOSE (43598-129-01)
1 NDC:43598-129-01 2 mL in 1 VIAL, SINGLE-DOSE This package is contained within the CARTON (43598-129-25)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA212396 03/24/2022
METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:43598-128
Route of Administration INTRAVENOUS, INTRAMUSCULAR DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
METHYLPREDNISOLONE SODIUM SUCCINATE (METHYLPREDNISOLONE) METHYLPREDNISOLONE 500 mg in 8 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 7.36 mg in 8 mL
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS 69.6 mg in 8 mL
Product Characteristics
Color WHITE (white to off-white) Score
Shape Size
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:43598-128-11 1 VIAL, MULTI-DOSE in 1 CARTON contains a VIAL, MULTI-DOSE
1 8 mL in 1 VIAL, MULTI-DOSE This package is contained within the CARTON (43598-128-11)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA212396 03/24/2022
METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:43598-130
Route of Administration INTRAVENOUS, INTRAMUSCULAR DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
METHYLPREDNISOLONE SODIUM SUCCINATE (METHYLPREDNISOLONE) METHYLPREDNISOLONE 1 g in 16 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 14.72 mL in 16 mL
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS 139.2 mg in 16 mL
Product Characteristics
Color WHITE (white to off-white) Score
Shape Size
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:43598-130-74 1 VIAL, MULTI-DOSE in 1 CARTON contains a VIAL, MULTI-DOSE
1 16 mL in 1 VIAL, MULTI-DOSE This package is contained within the CARTON (43598-130-74)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA212396 03/24/2022
Labeler — Dr. Reddy’s Laboratories Inc (802315887)
Registrant — Tianjin Kingyork Pharmaceuticals Co., Ltd (544518503)
Establishment
Name Address ID/FEI Operations
Tianjin Kingyork Pharmaceuticals Co., Ltd 544518503 analysis (43598-127), analysis (43598-128), analysis (43598-129), analysis (43598-130), manufacture (43598-127), manufacture (43598-128), manufacture (43598-129), manufacture (43598-130)

Revised: 05/2022 Dr. Reddy’s Laboratories Inc

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

https://medlibrary.org/lib/rx/meds/methylprednisolone-sodium-succinate-4/page/6/

Clinical Trials

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.